Skip to content
Laboratory Testing • Medical Research: 972-668-6005 |ayassbioscience@ayassbioscience.com
Laboratory Testing and Research Logo Laboratory Testing and Research Logo Laboratory Testing and Research Logo
  • Home
  • News
  • About
    • Ayass BioScience
    • About Dr. Ayass
    • Ayass BioScience Team
  • Services
    • Clinical
      • Laboratory Testing
      • COVID-19 Testing
    • Genetic
      • Cardiac Conditions
      • Hereditary Cancer
      • Pharmacogenetic Testing
    • Cytokine Testing
    • Transcriptome Analysis
      • F420 Program
      • Neuropathy
      • Obesity
    • Specimen Collection Instructions
    • R&D
  • R&D
    • Ayass Research Institute
    • F420 Program / Software
    • Fistoq, LLC
  • Publications
  • PORTAL
  • Videos/Brochures
  • Contact

September – Childhood Cancer Awareness Month

Previous Next
  • View Larger Image

September – Childhood Cancer Awareness Month

Larisa2020-09-08T10:11:43-05:00September 8th, 2020|Cancer Testing, Genetic Testing, Next Generation Sequencing|0 Comments

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInTumblrPinterestVkEmail

Related Posts

Cytokine Testing: A Game Changer for Clinical Trials
Cytokine Testing: A Game Changer for Clinical Trials
Gallery

Cytokine Testing: A Game Changer for Clinical Trials

Genetic sequencing at Ayass BioScience, LLC confirmed two cases in the Dallas-Fort Worth Metroplex

Genetic sequencing at Ayass BioScience, LLC confirmed two cases in the Dallas-Fort Worth Metroplex

2 Omicron Variant COVID-19 Cases Confirmed In North Texas by Ayass BioScience, LLC

2 Omicron Variant COVID-19 Cases Confirmed In North Texas by Ayass BioScience, LLC

COVID-19 Omicron Variant Confirmed In Two North Texas Patients By Ayass BioScience, LLC

COVID-19 Omicron Variant Confirmed In Two North Texas Patients By Ayass BioScience, LLC

Heart Disease and COVID-19
Heart Disease and COVID-19
Gallery

Heart Disease and COVID-19

Leave A Comment Cancel reply

Recent Posts

  • Aptamer-Enhanced Surface Decontamination April 8, 2025
  • Cytokine Testing: A Game Changer for Clinical Trials December 15, 2024
  • The Ion Torrent Sequencing Innovation Award from Thermo Fisher Scientific. December 8, 2024
  • The Frisco Physician Growing Hypo-Allergenic Peanuts October 4, 2024
  • Transcriptome Analysis September 21, 2023

Archives

Categories

  • Home
  • News
  • About
  • Ayass BioScience
  • About Dr. Ayass
  • Ayass BioScience Team
  • Services
  • Clinical
  • Laboratory Testing
  • COVID-19 Testing
  • Genetic
  • Cardiac Conditions
  • Hereditary Cancer
  • Pharmacogenetic Testing
  • Cytokine Testing
  • Transcriptome Analysis
  • F420 Program
  • Neuropathy
  • Obesity
  • Specimen Collection Instructions
  • R&D
  • R&D
  • Ayass Research Institute
  • F420 Program / Software
  • Fistoq, LLC
  • Publications
  • PORTAL
  • Videos/Brochures
  • Contact

VISIT US:

DISCLAIMER

The resources on Ayass BioScience, LLC. site should not be used as a substitute for professional medical care or advice. Please call us 972-668-6005 with any questions you might have.

TERMS OF SERVICE
PRIVACY POLICY

LATEST NEWS

  • Aptamer-Enhanced Surface Decontamination April 8, 2025
  • Cytokine Testing: A Game Changer for Clinical Trials December 15, 2024
  • The Ion Torrent Sequencing Innovation Award from Thermo Fisher Scientific. December 8, 2024

CONTACT FORM

    Your Name (required)

    Your Email (required)

    Subject

    Your Message

    Contact

    8501 Wade Blvd. Bldg. 9, Frisco, TX 75034

    Phone: 972-668-6005

    Fax: 972-635-4440

    Email: Email Link

    © AyassBioScience, LLC 2016-2024 | All Rights Reserved | Powered by WordPress
    Toggle Sliding Bar Area

    Laboratory Testing. Medical Testing. Medical Research.

    Laboratory Testing. Medical Testing. Medical Research.

    Ayass BioScience, LLC

    8501 Wade Blvd. Bldg 9, Frisco, TX 750934

    Phone: 972-668-6005

    Fax: 972-635-4440

    Email: ayassbioscience@ayassbioscience.com

    Page load link
    Go to Top